SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001053310-22-000002
Filing Date
2022-05-11
Accepted
2022-05-11 14:37:26
Documents
1
Period of Report
2022-05-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 5891
  Complete submission text file 0001053310-22-000002.txt   7451
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 225 LONG AVENUE HILLSIDE NJ 07205
Business Address
KAY E GERALD (Reporting) CIK: 0001053310 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31668 | Film No.: 22913222